David R. McAvoy insider trades

Open-market stock purchases and sales by David R. McAvoy, EVP, Chief Legal Officer at Teva Pharmaceutical Industries Ltd, from SEC Form 4 filings since Dec 21, 2018.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +76%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • TEVA Teva Pharmaceutical Industries Ltd: 1 buy, 2 sales, last Sep 5, 2025
  • FRTX Fresh Tracks Therapeutics, Inc: other filings, last Oct 2, 2023
  • BBI Brickell Biotech, Inc: 6 buys, last May 5, 2022
  • ECYT Endocyte Inc: other filings, last Dec 21, 2018

Get free alerts when David R. McAvoy files a new trade →